Harleysville, PA, United States of America

Robert W Hepler


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert W. Hepler: A Pioneer in Polysaccharide Research

Introduction

Robert W. Hepler, based in Harleysville, Pennsylvania, is a notable inventor recognized for his contributions in the field of molecular biology. With one patent to his name, he has demonstrated significant innovation in the area of polysaccharide antigens, which has potential applications in vaccine development.

Latest Patents

Hepler's patent encompasses a high molecular weight polysaccharide intracellular adhesin (SAE) antigen. This patent outlines its general structure as poly-1,6-β-2-amidoglucopyranoside, which varies in substituents such as N-acetyl and O-succinyl. In addition to the structural details, Hepler's work includes a method for isolating this antigen, which potentially serves crucial purposes in vaccine formulation. The SAE can be utilized either independently or in conjunction with immunogenic proteins or adjuvants, marking a significant advance in vaccine technology.

Career Highlights

Robert W. Hepler is associated with Merck & Company, Inc., a leading global pharmaceutical company. His role at Merck has allowed him to engage in innovative research and development, contributing valuable insights that further enhance the efficacy of vaccines and therapeutic agents.

Collaborations

Throughout his career, Hepler has collaborated with esteemed colleagues such as Joseph G. Joyce and James C. Cook, III. These collaborations highlight a team-based approach to research, underscoring the importance of collective expertise in driving forward advancements in medical science.

Conclusion

In summary, Robert W. Hepler stands out as a prominent figure in the field of polysaccharide research. His patent not only illustrates a remarkable innovation but also holds promise for future applications in vaccine development. His association with Merck & Company, Inc., along with effective collaborations, positions him as a valuable contributor to the advancement of medical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…